Ling Long1, Jinyun Chen2, Yu Xiong3, Min Zou3, Yongbin Deng3, Li Chen3, Zhibiao Wang1. 1. Department of Biomedical Engineering, State Key Laboratory of Ultrasound Engineering in Medicine, Chongqing Medical University No. 1 Yi Xue Yuan Road, Yu Zhong District, Chongqing 400016, China. 2. HIFU Center of 1st Affiliated Hospital of Chongqing Medical University No. 1 Yi Xue Yuan Road, Chongqing 400016, China. 3. Department of Gynecology, Chongqing HIFU Hospital No. 1 Qing Song Road, New North Zone, Chongqing 400000, China.
Abstract
OBJECTIVE: The aim of this study was to evaluate the efficacy, safety and sexual life quality outcomes of ultrasound-guided high-intensity focused ultrasound (HIFU) ablations for the treatment of patients with symptomatic adenomyosis and uterine volumes >200 cm(3). METHODS: In our prospective clinical trial 47 patients with uterine volumes >200 cm(3) and symptomatic adenomyosis were treated with single treatment sessions of ultrasound-guided HIFU ablations. Beside uterus and adenomyosis lesion size reductions, outcome measures were symptom severity score (SSS), visual analogue scale (VAS) of dysmenorrhea, female sexual function index (FSFI) scores and the incidence of complications. RESULTS: In all 47 patients, the adenomyosis lesions sizes were significantly reduced 12 months after the interventions (P<0.01). The SSS and dysmenorrhea VAS scores were significantly reduced 12 months after the interventions (P<0.01) and the FSFI scores gradually improved during 12 months after the HIFU ablations (P<0.001). No serious complication occurred. CONCLUSION: Ultrasound-guided HIFU ablation is a safe and effective noninvasive alternative for the treatment of uterine volumes >200 cm(3) with symptomatic adenomyosis. Particularly maintaining the integrity of patients' uteri leads to significant FSFI score improvements, which were essentially reduced before the HIFU treatments.
OBJECTIVE: The aim of this study was to evaluate the efficacy, safety and sexual life quality outcomes of ultrasound-guided high-intensity focused ultrasound (HIFU) ablations for the treatment of patients with symptomatic adenomyosis and uterine volumes >200 cm(3). METHODS: In our prospective clinical trial 47 patients with uterine volumes >200 cm(3) and symptomatic adenomyosis were treated with single treatment sessions of ultrasound-guided HIFU ablations. Beside uterus and adenomyosis lesion size reductions, outcome measures were symptom severity score (SSS), visual analogue scale (VAS) of dysmenorrhea, female sexual function index (FSFI) scores and the incidence of complications. RESULTS: In all 47 patients, the adenomyosis lesions sizes were significantly reduced 12 months after the interventions (P<0.01). The SSS and dysmenorrhea VAS scores were significantly reduced 12 months after the interventions (P<0.01) and the FSFI scores gradually improved during 12 months after the HIFU ablations (P<0.001). No serious complication occurred. CONCLUSION: Ultrasound-guided HIFU ablation is a safe and effective noninvasive alternative for the treatment of uterine volumes >200 cm(3) with symptomatic adenomyosis. Particularly maintaining the integrity of patients' uteri leads to significant FSFI score improvements, which were essentially reduced before the HIFU treatments.
Entities:
Keywords:
High-intensity focused ultrasound; adenomyosis; and dysmenorrhea; female sexual function index; symptom severity score
Authors: Izumi Imaoka; Susan M Ascher; Kazuro Sugimura; Kentaro Takahashi; Hong Li; Felicia Cuomo; James Simon; Lori L Arnold Journal: J Magn Reson Imaging Date: 2002-03 Impact factor: 4.813
Authors: O Yeniel; T Cirpan; M Ulukus; A Ozbal; G Gundem; S Ozsener; O Zekioglu; H Yilmaz Journal: Clin Exp Obstet Gynecol Date: 2007 Impact factor: 0.146